Literature DB >> 10852961

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.

L B Moore1, B Goodwin, S A Jones, G B Wisely, C J Serabjit-Singh, T M Willson, J L Collins, S A Kliewer.   

Abstract

St. John's wort (Hypericum perforatum) is an herbal remedy used widely for the treatment of depression. Recent clinical studies demonstrate that hypericum extracts increase the metabolism of various drugs, including combined oral contraceptives, cyclosporin, and indinavir. In this report, we show that hyperforin, a constituent of St. John's wort with antidepressant activity, is a potent ligand (K(i) = 27 nM) for the pregnane X receptor, an orphan nuclear receptor that regulates expression of the cytochrome P450 (CYP) 3A4 monooxygenase. Treatment of primary human hepatocytes with hypericum extracts or hyperforin results in a marked induction of CYP3A4 expression. Because CYP3A4 is involved in the oxidative metabolism of >50% of all drugs, our findings provide a molecular mechanism for the interaction of St. John's wort with drugs and suggest that hypericum extracts are likely to interact with many more drugs than previously had been realized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852961      PMCID: PMC16574          DOI: 10.1073/pnas.130155097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Acute heart transplant rejection due to Saint John's wort.

Authors:  F Ruschitzka; P J Meier; M Turina; T F Lüscher; G Noll
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

2.  LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.

Authors:  D Wheatley
Journal:  Pharmacopsychiatry       Date:  1997-09       Impact factor: 5.788

Review 3.  Controlled clinical trials of hypericum extracts in depressed patients--an overview.

Authors:  H P Volz
Journal:  Pharmacopsychiatry       Date:  1997-09       Impact factor: 5.788

4.  Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.

Authors:  V Butterweck; A Wall; U Liefländer-Wulf; H Winterhoff; A Nahrstedt
Journal:  Pharmacopsychiatry       Date:  1997-09       Impact factor: 5.788

5.  Indinavir concentrations and St John's wort.

Authors:  S C Piscitelli; A H Burstein; D Chaitt; R M Alfaro; J Falloon
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

6.  The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.

Authors:  S A Jones; L B Moore; J L Shenk; G B Wisely; G A Hamilton; D D McKee; N C Tomkinson; E L LeCluyse; M H Lambert; T M Willson; S A Kliewer; J T Moore
Journal:  Mol Endocrinol       Date:  2000-01

7.  An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.

Authors:  S A Kliewer; J T Moore; L Wade; J L Staudinger; M A Watson; S A Jones; D D McKee; B B Oliver; T M Willson; R H Zetterström; T Perlmann; J M Lehmann
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

8.  Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes.

Authors:  V Ramachandran; V E Kostrubsky; B J Komoroski; S Zhang; K Dorko; J E Esplen; S C Strom; R Venkataramanan
Journal:  Drug Metab Dispos       Date:  1999-10       Impact factor: 3.922

Review 9.  Herb-drug interactions.

Authors:  A Fugh-Berman
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

10.  St John's wort for depression--an overview and meta-analysis of randomised clinical trials.

Authors:  K Linde; G Ramirez; C D Mulrow; A Pauls; W Weidenhammer; D Melchart
Journal:  BMJ       Date:  1996-08-03
View more
  176 in total

1.  The best of both approaches. The role of science in complementary and alternative medicine.

Authors:  D O'Mathúna
Journal:  EMBO Rep       Date:  2001-12       Impact factor: 8.807

2.  Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.

Authors:  Steffen Bauer; Elke Störmer; Andreas Johne; Hagen Krüger; Klemens Budde; Hans-Hellmut Neumayer; Ivar Roots; Ingrid Mai
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

3.  Pregnane X receptor-mediated induction of Cyp3a by black cohosh.

Authors:  Xiaoyan Pang; Jie Cheng; Kristopher W Krausz; De-an Guo; Frank J Gonzalez
Journal:  Xenobiotica       Date:  2010-10-27       Impact factor: 1.908

Review 4.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 5.  St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

Authors:  L Henderson; Q Y Yue; C Bergquist; B Gerden; P Arlett
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

6.  Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception.

Authors:  Ute I Schwarz; Barbara Büschel; W Kirch
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

Review 7.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

Review 8.  Dietary effects on drug metabolism and transport.

Authors:  Robert Z Harris; Graham R Jang; Shirley Tsunoda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Pleomorphic hepatocellular carcinoma following consumption of hypericum perforatum in alcoholic cirrhosis.

Authors:  Evangeli S Lampri; Elli Ioachim; Haralampos Harissis; Eufemia Balasi; Antigoni Mitselou; Vasiliki Malamou-Mitsi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 10.  Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions.

Authors:  Sridhar Mani; Mohammed Ghalib; Imran Chaudhary; Sanjay Goel
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.